An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand

Thitiya Lukkunaprasit, Amarit Tansawet*, Suparee Boonmanunt*, Abhasnee Sobhonslidsuk, Gareth J McKay, John Attia, Ammarin Thakkinstian

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)
36 Downloads (Pure)

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a common cause of chronic liver disease and can progress to nonalcoholic steatohepatitis and cirrhosis. This study aims to summarize the evidence for the effects of curcumin on MAFLD progression. Studies were identified from Medline and Scopus databases until April 2022. Systematic reviews and meta-analyses (SRMA) and randomized controlled trials (RCT) were selected based on pre-specified criteria. Three reviewers independently extracted data and assessed quality of included studies. Of the 427 identified records, 6 SRMAs and 16 RCTs were included in the analysis. Very high overlap was observed among SRMAs with corrected covered area of 21.9%. From an updated meta-analysis, curcumin demonstrated significant improvement in aspartate and alanine aminotransferase with pooled mean difference [95% confidence interval (CI)] of -3.90 (-5.97, -1.82) and -5.61 (-9.37, -1.85) units/L, respectively. Resolution and improvement of hepatic steatosis was higher in curcumin than control group with pooled relative risk (95% CI) of 3.53 (2.01, 6.22) and 3.41 (1.36, 8.56), respectively. Curcumin supplementation also led to lower fasting blood sugar, body mass index, and total cholesterol. Further trials should be conducted to assess the effect of curcumin on liver histology, especially regarding non-invasive hepatic fibrosis and steatosis.

Original languageEnglish
Article number5824
JournalScientific Reports
Volume13
DOIs
Publication statusPublished - 10 Apr 2023

Bibliographical note

© 2023. The Author(s).

Keywords

  • Humans
  • Non-alcoholic Fatty Liver Disease/drug therapy
  • Curcumin/therapeutic use
  • Iran
  • Thailand
  • Liver Cirrhosis

Fingerprint

Dive into the research topics of 'An updated meta-analysis of effects of curcumin on metabolic dysfunction-associated fatty liver disease based on available evidence from Iran and Thailand'. Together they form a unique fingerprint.

Cite this